期刊文献+

一个遗传性出血性毛细血管扩张症家系的临床和遗传学分析 被引量:1

Clinical and Molecular Analysis of Patients from One Chinese Familiy with Heredi tary Hemorrhagic Telangiectasia
下载PDF
导出
摘要 目的 :对一个中国遗传性出血性毛细血管扩张症 (HereditaryHemorrhagicTelangiectasia ,HHT)家系的临床表现和遗传缺陷进行分析。方法 :对该HHT家系进行家系调查 ,并对所有成员进行临床检测。用PCR方法扩增ALK 1(Ac tivinReceptor LikeKinase 1)和Endoglin(ENG)基因的所有外显子、外显子 -内含子交界区和 5’、3’非翻译区 ,采用直接测序的方法查找基因突变。结果 :该家系的先证者有反复发作的鼻出血和皮肤粘膜的毛细血管扩张 ,并均有阳性家族史。各器官均未发现动静脉血管畸形。在家系的先证者及其他 4个成员中发现一个位于ALK 1基因第 8外显子G12 32A的错义突变 ,导致Arg 4 11Gln。结论 :HHT的临床表现多样。新错义突变G12 32A(Arg4 11Gln)可能导致HHT2的分子缺陷。该突变为国内首次报道。 Objective:To analysis the clinical features and genetic defects in ALK-1 and Endoglin gene from one Chinese pedigree with hereditary hemorrhag ic telangiectasia (HHT). Method:A detailed medical history and clinical detection was pe rformed on all members of the pedigree and peripheral blood sample collected.A ll exons and intron-exon boundaries of ALK-1 and Endoglin genes were amplified by polymerase chain reaction (PCR) and directly sequenced. Results:All affected members of the pedigree have epistaxis,te langiectases and positive family history of HHT with no systemic arteriovenous m alformations.In the pedigree,G1232A missense mutation in exon 8 of ALK-1 gen e,which changes Arg411 to Gln,is identified in proband and other four clinical ly affected relatives.No mutation of Endoglin gene is detected in all affected individuals.Conclusion:The clinical presentations of HHT are variable.The missense mutation G1232A in exon 8 of ALK-1 gene,first reported in China,is p ossibly the molecular defects casuing the HHT in the pedigree.
出处 《微循环学杂志》 2005年第1期62-64,共3页 Chinese Journal of Microcirculation
  • 相关文献

参考文献10

  • 1王鸿利 于立志 见邓家栋 杨崇礼 杨天楹 等主编.遗传性出血性毛细血管扩张症[A].见邓家栋,杨崇礼,杨天楹,等主编.邓家栋临床血液学.第二版[C].上海:上海科学技术出版社,2001.1367-1373.
  • 2Heutink P, Haitjema T, Breedveld GJ, et al. Linkage of hereditary haemorrhagic telangiectasia to chromosome 9q34 and evidence for locus heterogeneity. J Med Genet,1994,31: 933~936.
  • 3McAllister KA, Lennon F, Bowles-Biesecker B,et al.Genetic heterogeneity in hereditary haemorrhagic telangiectasia: possible correlation with clinical phenotype. J Med Genet,1994, 31: 927~932.
  • 4Piantanida M, Buscarini E, Dellavecchia C, et al. Hereditary haemorrhagic telangiectasia with extensive liver involvement is not caused by either HHT1 or HHT2. J Med Genet,1996,33:441~443.
  • 5McAllister KA,Grogg KM,Johnson DW,et al. Endoglin,a TGF-β binding protein of endothelial cells,is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet, 1994,8:345~351.
  • 6Berg JN, Gallione CJ, Stenzel TT, et al. The activin receptor-like kinase 1 gene: genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2. Am J Hum Genet,1997,61:60~67.
  • 7Abdalla SA, Cymerman U, Johnson RM, et al. Disease-associated mutations in conserved residues of ALK-1 kinase domain. Eur J Hum Genet, 2003,11:279~287.
  • 8Harrison RE, Flanagan JA, Sankelo M, et al. Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia. J Med Genet,2003,40:865~871.
  • 9Abdalla SA, Geisthoff UW, Bonneau D, et al. Visceral manifestations inhereditary haemorrhagic telangiectasia type 2 J Med Genet, 2003,40:494~5 026.
  • 10van den Driesche S, Mummery CL, Cornelius JJ, et al. Hereditary hemorrhagic telangiectasia: an update on transforming growth factor b signaling in vasculogenesis and angiogenesis.Cardiovascular Res,2003, 58:20~31.

同被引文献10

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部